Entry |
|
Name |
Varespladib methyl (USAN) |
Formula |
C22H22N2O5
|
Exact mass |
394.1529
|
Mol weight |
394.4205
|
Structure |
|
Simcomp |
|
Remark |
|
Efficacy |
Antidyslipidemia, Secretory phospholipase A2 (sPLA2) inhibitor |
Comment |
Treatment of dyslipidemia
|
Target |
|
Pathway |
|
Brite |
Target-based classification of drugs [BR:br08310]
Enzymes
Hydrolases (EC3)
Carboxylic-ester hydrolases
PLA2G7 (LP-PLA2)
D08221 Varespladib methyl (USAN)
|
Other DBs |
|
KCF data |
ATOM 29
1 C1b C 18.8618 -19.4247
2 C8y C 20.1235 -20.1256
3 N4y N 18.8618 -18.0228
4 C8x C 20.1235 -21.5275
5 C8x C 21.3150 -22.2284
6 C8x C 22.5066 -21.5275
7 C8x C 22.5066 -20.1256
8 C8x C 21.3150 -19.4247
9 C8y C 19.9833 -17.1817
10 C8y C 19.5627 -15.8499
11 C8y C 18.1608 -15.8499
12 C8y C 17.7403 -17.1817
13 C8y C 17.2496 -14.8686
14 C8x C 15.8478 -15.1490
15 C8x C 15.4272 -16.4808
16 C8x C 16.4085 -17.5322
17 C1b C 21.1749 -17.8826
18 C1a C 22.4365 -17.1817
19 C5a C 20.2636 -14.6583
20 C5a C 21.6655 -14.6584
21 N1a N 22.3664 -13.4667
22 O5a O 19.5627 -13.4667
23 O5a O 22.3664 -15.9200
24 O2a O 17.6702 -13.5368
25 C1b C 16.6889 -12.4854
26 C7a C 15.3107 -12.8332
27 O6a O 14.3333 -11.8268
28 O7a O 14.9363 -14.1535
29 C1a C 13.5576 -14.5020
BOND 31
1 1 2 1
2 1 3 1
3 2 4 2
4 4 5 1
5 5 6 2
6 6 7 1
7 7 8 2
8 2 8 1
9 3 9 1
10 9 10 2
11 10 11 1
12 11 12 1
13 3 12 1
14 11 13 2
15 13 14 1
16 14 15 2
17 15 16 1
18 12 16 2
19 9 17 1
20 17 18 1
21 10 19 1
22 19 20 1
23 20 21 1
24 19 22 2
25 20 23 2
26 13 24 1
27 24 25 1
28 25 26 1
29 26 27 2
30 26 28 1
31 28 29 1
|